Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Uterine Cervical Neoplasms × Pemetrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Carcinoma 3 Mesothelioma 2 Uterine Cervical Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

pembrolizumab 3 tisotumab vedotin 2 Cisplatin 2 sacituzumab govitecan 1 Vinorelbine 1 Topotecan 1 Saline Solution 1 Pemetrexed 1 Paclitaxel 1 Irinotecan 1 Gemcitabine 1 Carboplatin 1 Brachytherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04697628 2026-02-24

innovaTV 301

Seagen Inc.

Phase 3 Completed

502 enrolled 18 charts 1 FDA

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡